Pharma-Bio Serv Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Capitalization	13	12	13	20	20	24
Market Cap Growth	-13.30%	-7.06%	-31.76%	-1.11%	-16.81%	-20.06%
Enterprise Value	4	2	1	5	6	8
Last Close Price	0.56	0.47	0.44	0.60	0.57	0.58
PE Ratio	210.66	-	-	14.89	19.60	-
Forward PE	5.65	208.00	208.00	208.00	208.00	208.00
PS Ratio	1.42	1.38	1.40	1.15	1.02	1.18
PB Ratio	1.24	1.04	0.97	1.21	1.19	1.25
P/TBV Ratio	1.24	1.04	0.97	1.21	1.19	1.25
P/FCF Ratio	-	-	-	10.36	34.42	29.87
P/OCF Ratio	-	-	-	10.32	33.31	29.47
PEG Ratio	-	14.86	14.86	14.86	14.86	14.86
EV/Sales Ratio	0.49	0.19	0.07	0.31	0.31	0.39
EV/EBITDA Ratio	-	-	-	4.56	4.91	-
EV/EBIT Ratio	-	-	-	4.75	5.12	-
EV/FCF Ratio	-	-	-	2.82	10.49	9.97
Debt / Equity Ratio	-	0.00	0.01	0.02	0.03	0.03
Debt / EBITDA Ratio	-	-	-	0.26	0.35	-
Debt / FCF Ratio	-	-	-	0.18	0.85	0.78
Net Debt / Equity Ratio	-0.81	-0.91	-0.91	-0.91	-0.84	-0.89
Net Debt / EBITDA Ratio	25.14	18.74	9.93	-12.55	-11.40	4.46
Net Debt / FCF Ratio	34.39	48.87	17.28	-7.77	-24.38	-21.22
Asset Turnover	0.72	0.60	0.53	0.84	0.87	0.75
Quick Ratio	10.71	7.60	8.08	8.78	9.23	8.27
Current Ratio	10.80	7.70	8.32	9.01	9.46	8.55
Return on Equity (ROE)	0.55%	-0.78%	-5.21%	8.02%	5.68%	-10.04%
Return on Assets (ROA)	-1.95%	-2.66%	-4.45%	3.44%	3.29%	-8.95%
Return on Invested Capital (ROIC)	-41.38%	-56.62%	-96.81%	42.55%	42.85%	-74.35%
Return on Capital Employed (ROCE)	-3.80%	-5.40%	-8.90%	6.30%	6.30%	-18.10%
Earnings Yield	0.48%	-0.81%	-5.84%	6.71%	5.10%	-8.81%
FCF Yield	-1.90%	-1.79%	-5.46%	9.65%	2.90%	3.35%
Payout Ratio	2793.16%	-	-	131.57%	342.37%	-
Buyback Yield / Dilution	0.09%	0.07%	0.10%	0.15%	0.56%	-0.53%